Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prichard

Showing results (271-280 of 1,778) with videos related to

Pageof 178
Sort By:
Antimicrobial Agents and Chemotherapy|June 11, 1991
Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudineM N Prichard, L E Prichard, W A Baguley, et al.
Antiviral Research|March 13, 2012
Orthopoxvirus targets for the development of new antiviral agentsMark N Prichard, Earl R Kern
Primary Care|September 1, 1990
Current issues in NSAID therapyL G Miller, J G Prichard
International Journal for Parasitology. Drugs and Drug Resistance|June 24, 2019
Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistanceRoger K Prichard, Timothy G Geary
Appetite|March 12, 2022
The effectiveness of implicit interventions in food menus to promote healthier eating behaviours: A systematic reviewIndah Gynell, Eva Kemps, Ivanka Prichard
Parasitology Research|December 22, 1999
Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus)M B Molento, R K Prichard
Molecular and Biochemical Parasitology|September 25, 1999
Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulusY J Huang, R K Prichard
Health Physics|April 1, 1975
The technologically enhanced natural radiation environmentT F Gesell, H M Prichard
Drugs|October 1, 1985
Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacyB N Prichard, R N Brogden
Australian and New Zealand Journal of Medicine|October 1, 1984
Lung function in diffuse interstitial lung disease of unknown causeK E Finucane, M G Prichard
Pageof 178

Showing results (271-280 of 1,778) with videos related to

Sort By:
Pageof 178
Antimicrobial Agents and Chemotherapy|June 11, 1991
Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudineM N Prichard, L E Prichard, W A Baguley, et al.
Antiviral Research|March 13, 2012
Orthopoxvirus targets for the development of new antiviral agentsMark N Prichard, Earl R Kern
Primary Care|September 1, 1990
Current issues in NSAID therapyL G Miller, J G Prichard
International Journal for Parasitology. Drugs and Drug Resistance|June 24, 2019
Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistanceRoger K Prichard, Timothy G Geary
Appetite|March 12, 2022
The effectiveness of implicit interventions in food menus to promote healthier eating behaviours: A systematic reviewIndah Gynell, Eva Kemps, Ivanka Prichard
Parasitology Research|December 22, 1999
Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus)M B Molento, R K Prichard
Molecular and Biochemical Parasitology|September 25, 1999
Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulusY J Huang, R K Prichard
Health Physics|April 1, 1975
The technologically enhanced natural radiation environmentT F Gesell, H M Prichard
Drugs|October 1, 1985
Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacyB N Prichard, R N Brogden
Australian and New Zealand Journal of Medicine|October 1, 1984
Lung function in diffuse interstitial lung disease of unknown causeK E Finucane, M G Prichard
Pageof 178